Classic Agro-Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 5.50 Cr
as on 26-12-2024
- Revenue 14.62%
(FY 2016)
- Profit 15.72%
(FY 2016)
- Ebitda 864.75%
(FY 2016)
- Net Worth 97.10%
(FY 2016)
- Total Assets 2172.54%
(FY 2016)
About Classic Agro-Bioscience
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.50 Cr.
Chetan Nandavani and Mukund Kokil serve as directors at the Company.
- CIN/LLPIN
U15364MH2005PTC153642
- Company No.
153642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2005
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Classic Agro-Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Nandavani  | Additional Director | 05-Oct-2016 | Current |
| Mukund Kokil | Director | 17-Feb-2015 | Current |
Financial Performance of Classic Agro-Bioscience.
Classic Agro-Bioscience Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 14.62% increase. The company also saw a substantial improvement in profitability, with a 15.72% increase in profit. The company's net worth Soared by an impressive increase of 97.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Classic Agro-Bioscience?
In 2016, Classic Agro-Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pawar Patkar And D. S. Contractors Associates Private LimitedActive 15 years 6 monthsChetan Nandavani is a mutual person
- Smit Advanced Agro Invention Private LimitedActive 17 years 4 months
Mukund Kokil is a mutual person
Charges (Loans)
₹55.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2015 | Others | ₹5.50 Cr | Open |
How Many Employees Work at Classic Agro-Bioscience?
Unlock and access historical data on people associated with Classic Agro-Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Classic Agro-Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Classic Agro-Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
